The NeoPODS study evaluated Masimo’s SET pulse oximetry in 100 hospitalized newborns, using 136 paired SpO2-SaO2 measurements from 70 patients meeting strict criteria. Researchers employed objective ...
Masimo’s NeoPODS study in critically ill newborns found its SET pulse oximetry technology delivered consistent accuracy across all skin tones, with less than 1% bias. The findings address longstanding ...